Keyword: St. Jude Medical
Procyrion will advance its heart failure pump through a pilot study and toward a pivotal trial.
The takeover will give Otsuka an ultrasound ablation system that lowered the blood pressure of hypertension patients in a recent clinical trial.
The FDA has cleared Abbott’s smartphone-compatible ICM, which facilitates the remote monitoring of patients with arrhythmias.
Here's Wednesday's medtech news of note.
The FDA approved MR-conditional labeling for the Ellipse implantable cardioverter defibrillator.
Here is Wednesday's medtech news of note.
Here's Wednesday's dose of medtech news of note.
The update is intended to fix a cybersecurity weakness that allowed hackers to affect the battery life and pacing of 465,000 devices in the U.S.
After a year of back and forth, Abbott and Alere are finally nearing a $5.3 billion acquisition. The St. Jude buy rounded out Abbott’s cardiovascular business, but to make room for investment and long-term growth in the space, the company sold off Abbott Medical Optics.
Stimwave scored FDA clearance for its tiny, injectable, MRI-safe neurostimulator for chronic peripheral nerve pain.